PATENT CLAIM ANALYSIS

Application Number: 16138486
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-08
Patent Classification: ["424", "085600"]

Abstract:
Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.

Claim (Index 31):
The method of  claim 28 , wherein the neuroimagining parameter is Radial Diffusivity.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 97.0
- Lexical Diversity: 1.32
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14580818', '14033707', '15155815', '15201300', '15597021']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6532373834967592
- 35 USC 102 Novelty (BERT): 0.5132878620673051
- Combined Prediction Score: 0.6392424313538139
- Mean Citation Score: 186.722654
- Max Citation Score: 191.59985
- Similarity Product: 103.61223778113128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test